Amorphous Umbralisib Monotosylate

摘要

The present disclosure provides amorphous umbralisib monotosylate, and a method for preparing the same; a pharmaceutical composition comprising amorphous umbralisib monotosylate; and to methods of treating a patient using amorphous umbralisib monotosylate.